{
    "id": "dbpedia_6735_2",
    "rank": 20,
    "data": {
        "url": "https://www.evidentscientific.com/en/",
        "read_more_link": "",
        "language": "en",
        "title": "NDT, Microscopes, XRF, RVI",
        "top_image": "https://www.evidentscientific.com/android-chrome-192x192.png?rev=A103",
        "meta_img": "https://www.evidentscientific.com/android-chrome-192x192.png?rev=A103",
        "images": [
            "https://www.evidentscientific.com/styles/evident/data/c/logo.png?rev=207D",
            "https://www.evidentscientific.com/styles/evident/data/c/logo-olympus.png?rev=24AB",
            "https://www.evidentscientific.com/styles/evident/data/c/logo-olympus-white.png?rev=207D",
            "https://www.evidentscientific.com/data/image/Content/evident-logo-blue.jpg?rev=3941",
            "https://www.evidentscientific.com/data/image/home/featured-pages/IOTY.jpg?rev=3F00",
            "https://www.evidentscientific.com/data/image/home/featured-pages/IMS.jpg?rev=3F00",
            "https://www.evidentscientific.com/data/image/home/featured-pages/LS.jpg?rev=3F00",
            "https://www.evidentscientific.com/data/Media/home-brand-play.png?rev=7852",
            "https://www.evidentscientific.com/modules/imageresizer/1jn/n4f/01l5j58nhh/800x450p3078x2140.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/3p3/9pe/pb7dba8o1h/800x450p3959x2640.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/6ph/qa9/p1j97micn2/200x150p2880x1920.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/6fe/g7l/4395qm5c7g/200x150p4795x2530.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/elf/il5/g3p99kjo79/200x150p400x400.png",
            "https://www.evidentscientific.com/modules/imageresizer/212/eo7/4glog74fo6/200x150p1200x800.jpg",
            "https://www.evidentscientific.com/modules/news/image_209715285.jpg?rev=E95B",
            "https://www.evidentscientific.com/modules/imageresizer/9k8/cjd/1oqoh3iq7q/200x150p340x308.png",
            "https://www.evidentscientific.com/modules/imageresizer/3ob/5j3/kdhpnb3f2g/200x150p250x250.jpg",
            "https://www.evidentscientific.com/modules/news/image_209715282.jpg?rev=C98C",
            "https://www.evidentscientific.com/modules/imageresizer/2nh/6iq/ghoe7eo989/200x150p2880x1920.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/1l9/342/ccjgcno9hm/200x150p960x540.png",
            "https://www.evidentscientific.com/modules/imageresizer/824/7k5/k71nlp6n25/200x150p300x200.png",
            "https://www.evidentscientific.com/modules/imageresizer/4n9/bg3/0eqclpic1l/200x150p254x185.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/3h1/5h0/9mji7abcm6/200x150p400x300.jpg",
            "https://www.evidentscientific.com/modules/news/image_209715276.jpg?rev=3689",
            "https://www.evidentscientific.com/modules/imageresizer/36h/im3/a85kjha3fm/200x150p605x395.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/1gi/m9q/kip1695geo/200x150p400x280.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/5lb/ned/88lj8f7me9/200x150p400x280.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/5fp/516/k3daefbcdj/200x150p960x540.png",
            "https://www.evidentscientific.com/modules/imageresizer/2ed/431/q1dq4j80ao/200x150p300x200.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/8bp/8g2/plaqq2e6q3/200x150p400x280.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/2g2/o95/g5e1d58j40/200x150p760x661.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/15a/bc8/193mn4dbmn/200x150p675x448.png.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/5a9/ed4/959l72fpqi/200x150p400x280.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/80n/pfh/74ma65kcna/200x150p300x200.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/1bh/n82/j517kb5hon/200x150p400x280.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/463/67n/a5f99bc059/200x150p1560x1040.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/7j7/edm/ndfcqfo70m/200x150p325x140.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/2q9/kok/0f2h7a3b7k/200x150p260x174.jpg",
            "https://www.evidentscientific.com/modules/news/image_209715260.jpg?rev=5E34",
            "https://www.evidentscientific.com/modules/imageresizer/4e0/64b/faq653hq61/200x150p260x160.png",
            "https://www.evidentscientific.com/modules/imageresizer/20j/4h0/1kij6cnf33/200x150p400x280.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/qqb/2h4/6hfcpi7mg4/200x150p400x300.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/3eh/688/57q2j9b6ea/200x150p960x540.png",
            "https://www.evidentscientific.com/modules/news/image_209715256.jpg?rev=EF5B",
            "https://www.evidentscientific.com/modules/news/image_209715255.jpg?rev=B57B",
            "https://www.evidentscientific.com/modules/imageresizer/m6q/cb5/ah0ap4649f/200x150p270x195.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/3i8/2mq/fd3l143ilf/200x150p960x540.png",
            "https://www.evidentscientific.com/modules/imageresizer/523/flk/i3ddbm8mgb/200x150p600x400.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/4fd/pdl/mcq84lae2k/200x150p600x351.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/40d/q99/7han7q36bh/200x150p960x540.png",
            "https://www.evidentscientific.com/modules/imageresizer/6q0/cgb/6ql853p64c/200x150p300x200.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/bgl/i88/6o782969aj/200x150p500x201.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/72f/1nb/37knjfoch8/200x150p855x533.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/1dn/kjc/90aqdbqd5l/200x150p300x225.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/3n7/agq/kdhjkgc8o9/200x150p600x600.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/2b0/oda/f13gi5c4kl/200x150p600x240.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/83k/ddg/fgc9470lhb/200x150p400x300.jpg",
            "https://www.evidentscientific.com/modules/news/image_209715240.jpg?rev=C7EC",
            "https://www.evidentscientific.com/modules/imageresizer/k4g/5pa/l8m1o4h05g/200x150p2592x1944.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/1jb/8jf/aqa3cgko3c/200x150p260x195.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/2qn/2co/5g54q39edh/200x150p450x320.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/77h/1o6/kf64pm2l9b/200x150p600x600.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/52f/p2j/qj8ko3j8ed/200x150p260x195.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/290/5mg/k23p0o67m6/200x150p500x500.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/385/9hb/d0j6epj3cm/200x150p600x600.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/468/qop/68l17gn03n/200x150p500x500.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/5f2/ij9/dcd07okfjj/200x150p2866x1911.jpg",
            "https://www.evidentscientific.com/modules/imageresizer/7ac/mof/49imjp410a/200x150p600x450.jpg",
            "https://www.evidentscientific.com/modules/news/image_209715214.jpg?rev=D38C",
            "https://www.evidentscientific.com/modules/imageresizer/781/o9f/gi11pl2f4a/650x434p600x400.jpg",
            "https://www.evidentscientific.com/data/image/support/footer-banner-compliancechip-2.png?rev=3B7B"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Home",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico?ver2303301016",
        "meta_site_name": "",
        "canonical_link": "https://www.evidentscientific.com/en/",
        "text": "What's New\n\nNew Product\n\nThe new 39DL PLUS™ ultrasonic thickness gauge redefines efficiency in the NDT industry with ultra-fast scanning speeds and fully integrated wireless connectivity in a rugged handheld design. Find out more in the press release.\n\nExplore the future of nondestructive testing at WCNDT, May 27–31 in South Korea! Exclusive Sponsor of this year’s event, we’ve organized presentations offering insights on industry-shaping innovations. Find out more in this press release.\n\nNotice\n\nPRECiV DSX software is redefining the reliability, precision, and ease of use of DSX1000 digital microscopes. Read the press release to learn more.\n\nNotice\n\nEase weld and corrosion inspections of hard-to-reach and high-temperature parts with our redesigned MapROVER™ and SteerROVER™ scanners. Read about the scanners’ new features and enhancements in this press release.\n\nNews\n\nInspecting girth welds during pipeline construction is often performed under extreme conditions. The PipeWIZARD™ iX AUT system is optimized to ease this challenging application. Read the press release.\n\nNotice\n\nOur fifth annual Image of the Year competition is now open for entries! For the first time, the 2024 contest welcomes video submissions to show the art of capturing moving images under the microscope. Learn more in the press release.\n\nNew Product\n\nThe ultra-thin IPLEX TX II videoscope combines the versatility of a 2.2 mm diameter flexible scope with a 1.8 mm rigid scope in a single package. With improved durability, maneuverability, illumination, and image quality, the IPLEX TX II provides better imaging in small spaces. Read about all the improvements in the press release.\n\nNews\n\nEvident donates three million Japanese yen to support relief efforts for the Noto Peninsula earthquake in Japan.\n\nNews\n\nOur next-generation Vanta™ handheld XRF analyzers—Vanta Max and Vanta Core—combine performance with comfort to maximize efficiency for field and lab professionals. Learn more in the press release.\n\nNotice\n\n株式会社XMATの面政也代表取締役、東北大学未来科学技術共同研究センターの吉川彰教授と大橋雄二准教授、日本大学工学部の岩城一郎教授と前島拓講師、株式会社復建技術コンサルタントの飯土井剛副部長および株式会社エビデントの共同研究により開発された「非破壊検査と拡張現実技術を融合したインフラ点検システム」が、2023年11月16日、東北経済産業局が主催する「TOHOKU DX大賞2023」において、製品・サービス部門の最優秀賞（東北経産局長賞）を受賞したことをお知らせします。\n\nNotice\n\n株式会社エビデント（本社：東京都新宿区、社長：吉本浩之）は、U-16プログラミングコンテスト八王子大会実行委員会が主催する「U-16プログラミングコンテスト八王子大会」を、今年から協賛し応援します。\n\nNew Product\n\nOur new DP75 digital microscope camera is breaking new ground in microscopic imaging! Users can now capture brightfield or wide-wavelength fluorescence images using a single color camera. And that’s just the beginning. Check out the press release for details about this high-end camera’s new features.\n\nNews\n\n株式会社エビデント（本社：東京都新宿区、社長：吉本浩之）のグループ会社であり、顕微鏡、工業用内視鏡などの製造・修理を手掛ける株式会社エビデント長野（本社：長野県上伊那郡辰野町、社長：小山健一）の社員、下平 隆弘（しもだいら たかひろ）がレンズ研磨工・加工工で評価され、令和5年度の「信州の名工」を受賞することになりましたのでお知らせいたします。表彰式は11月10日（金）に長野市で行われます。\n\nNews\n\nEvident was established as a standalone company in April 2023, comprising the former Scientific Solutions business of Olympus, marking a significant milestone in the development of our new company.\n\nNew Product\n\nIntroducing the FLUOVIEW™ FV4000 confocal laser scanning microscope and FV4000MPE multiphoton laser scanning microscope—groundbreaking advancements in imaging technology that empower researchers to make new scientific discoveries. Learn about all the new features and functions in the press release.\n\nNew Product\n\nWe’ve updated the software for our LEXT OLS5100 laser scanning microscope to streamline experiment management and add helpful new functions to make your experiments faster and efficient. Learn more in the press release.\n\nNews\n\n株式会社エビデント（本社：東京都新宿区、社長：吉本浩之）のグループ会社であり、顕微鏡、工業用内視鏡などの製造・修理を手掛ける株式会社エビデント長野（本社：長野県上伊那郡辰野町、社長：小山健一）は、2023年10月19日（木）から21日（土）まで開催される「諏訪工業メッセ2023」に初出展します。\n\nNotice\n\n理化学研究所とエビデントの共同研究グループは、ホタル由来の発光遺伝子を導入し、異なる波長で非常に明るく発光する2種の新しいマウス系統を開発し、生体深部組織の発光イメージングを飛躍的に改善させました。\n\nNews\n\n株式会社エビデント（本社：東京都新宿区、社長：吉本浩之）は、2023年9月13日(水)から15日(金)まで東京ビッグサイトで開催される「測定計測展2023」に、直感操作によってサンプルの欠陥箇所を学習させ、対象物の凹み、傷、穴などの欠陥有無やその種別判定を自動化する外観検査AIと当社デジタルマイクロスコープ「DSX1000」を組み合わせたシステムを初出展します。\n\nNews\n\n独立行政法人国立病院機構呉医療センター・中国がんセンター（院長：下瀨 省二）を含む国内医療機関7施設との共同研究で開発した胃がんAI病理診断支援ソフトウェアが、学習データに使用していない施設での連続症例における評価でAUC0.96を達成しました。\n\nNews\n\nEvident Corporation (“Evident”) announced the appointment of William Wesley “Wes” Pringle as Chief Executive Officer (CEO) and Hiroyuki Yoshimoto as President and Chief Operating Officer (COO). Effective immediately, Wes takes over for Evident’s interim CEO Eric Anderson.\n\nNews\n\nThe results are in! Discover the winners of our 2022 Global Image of the Year Scientific Light Microscopy Award, an annual competition that recognizes the best in scientific imaging worldwide. Learn more in the press release.\n\nNews\n\n株式会社エビデント（本社：東京都新宿区、社長：エリック アンダーソン）は、2023年7月26日（水）から28日（金）まで東京ビッグサイトで開催される「第11回非破壊評価総合展」に、国内初公開となる超音波フェーズドアレイ技術を搭載した自動検査ロボットソリューションを含む、非破壊検査機器のラインナップを出展します。\n\nNews\n\n株式会社エビデント（本社：東京都新宿区、社長：エリック アンダーソン）は、2023年7月5日（水）から7日（金）までAichi Sky Expo（愛知県国際展示場）で開催される「人とくるまのテクノロジー展 NAGOYA 2023」に出展します。今回は、2023年度の販売開始を予定している極細径の工業用ビデオスコープ（外径2.2ミリ、1.8ミリ）を初公開します。また、近年増加傾向にある電動車（xEV）および自動車開発において研究の初期段階から製造検査、品質管理まで幅広い工程で活用される当社の非破壊検査・測定ソリューションとその最新事例を紹介します。\n\nNews\n\nTogether with the University of Montreal’s School of Optometry and the Centre interdisciplinaire de recherche sur le cerveau et l l’apprentissage (CIRCA), we celebrated the inauguration of the campus’ new Evident Discovery Center! Learn more in the press release.\n\nNew Product\n\nOur new SLIDEVIEW DX enables fast, efficient digital pathology with microscope-quality images onscreen and fast slide scanning. Get all the details in the press release.\n\nNew Product\n\n株式会社エビデント（本社：東京都新宿区、社長：エリック アンダーソン）は、病理検査向けにスライドガラス標本を画像データ化するホールスライドイメージングシステム「SLIDEVIEW VS-M1J（スライドビュー ヴイエス-エムワンジェイ）」を2023年6月1日より国内で発売します。\n\nNews\n\nEvident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective immediately.\n\nNews\n\n株式会社エビデントは、レーザー顕微鏡およびデジタルマイクロスコープによる寸法測定において、公益財団法人日本適合性認定協会（JAB）から試験や校正の技術的能力があると国際的に認められた施設に与えられるISO/IEC 17025の認定を2023年4月4日付けで取得しました。これにより、自社において国際規格に基づいた校正業務が行えるようになります。詳細はニュースリリースをご覧ください。\n\nNew Product\n\nNew SLIDEVIEW VS200 v. 4.1 software adds support for a host of new features, including the new SILA optical sectioning device that enables users to obtain high-contrast images from deep within their samples. Learn about all the new features in the press release.\n\nNews\n\n株式会社エビデント（本社：東京都新宿区、社長：齋藤 吉毅）は、従業員の健康増進のためにスポーツ活動の促進・支援に積極的に取り組んでいる企業として、スポーツ庁による「スポーツエールカンパニー」に認定されました。\n\nNotice\n\n2023年4月8日13時頃から、当社支店営業所および相模原ロジスティックスの外線電話に障害が発生し、お電話がつながりにくい状況となりました。現在、復旧いたしましたことをご報告させていただきます。\n\nNews\n\nNew PRECiV 1.2 software adds simple-to-use advanced imaging and measurement tools that make production, quality control, and inspection more efficient. Get all the details about these powerful new features in the press release.\n\nNotice\n\nOn February 8, we’re hosting a virtual organoid conference that brings experts together from around the Asia-Pacific region to discuss their research. Learn more about the conference in this press release.\n\nNews\n\nOur new Vanta GX precious metal analyzer is an affordable way to know the purity and composition of gold, jewelry, coins, and other valuables. Read the press release to learn more.\n\nNews\n\n東北大学未来科学技術共同研究センターおよび日本大学工学部は、株式会社エビデント、株式会社復建技術コンサルタント、株式会社XMATと共同で、コンクリート塩分濃度測定を１ヶ月から30秒に大幅短縮する新奇コンクリート塩分濃度測定技術を開発。本技術は国土交通省の新技術情報提供システム（NETIS）にも登録されています。詳細はニュースリリースをご覧ください。\n\nNews\n\nTo meet the challenges of wind power gearbox inspections—such as cramped quarters, oil environments, and hard-to-reach areas—we created the compact, powerful IPLEX G Lite-W videoscope. Learn more in the press release.\n\nNews\n\nWe’re collaborating with Ultivue, Inc., a leader in multiplexing tools and novel image analysis solutions for biomarker studies, to promote whole slide imaging using multiplexed immunofluorescence (mIF) assays to advance translational research. Get the details in the press release.\n\nNews\n\nEvident announced the opening of its new Asia-Pacific (APAC) headquarters in Singapore, marking its ongoing commitment to expand its business and operations in the APAC region.\n\nNews\n\nSakura Finetek—a global leader in histopathology products—and Evident are collaborating to offer a full workflow solution for anatomic pathology slide preparation and high-resolution digital scanning. Learn more in the press release.\n\nNews\n\nWe just announced our fourth Global Image of the Year Scientific Light Microscopy competition! This year, for the first time, we’re welcoming materials science in addition to life science images. Get the details in the press release.\n\nNews\n\nThe results show the diagnostic tool in development succeeded in expanding its AI detection to seven types of gastric cancer, highlighting its versatility for a range of pathology applications.\n\nNews\n\nOlympus Corporation (“Olympus”) and EVIDENT Co., Ltd. (\"Evident\"), a wholly-owned subsidiary of Olympus announced today that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to Bain Capital on January 4, 2023, subject to regulatory approvals and closing conditions.\n\nNews\n\nOur new MXPLFLN series objectives enable OEM and industrial microscopy users to take advantage of our cutting-edge manufacturing technology to obtain images with better flatness, higher resolution, and a long, 3 mm working distance at the same time. Learn more in the press release.\n\nNews\n\nOur new SZX-AR1 augmented reality system easily retrofits to existing SZX series stereo microscopes to simplify complex microscope-based manufacturing tasks. Get all the details in the press release.\n\nNews\n\nOur new APEXVIEW APX100 imaging system combines the ease of use of an all-in-one microscope with publication-quality images. Read about the system’s benefits, including an advanced AI and our renowned optics, in this press release.\n\nNews\n\nEvident’s 2021 microscope Image of the Year winners have just been announced! Read the press release to see the stunning images and learn about the winners.\n\nNews\n\nOur new SZX-AR1 augmented reality system easily retrofits to existing SZX series stereo microscopes to simplify complex microscope-based manufacturing tasks. Get all the details in the press release.\n\nNews\n\nOur newest microscope camera delivers quality brightfield images in a cost-effective package. Learn more in the press release.\n\nNews\n\nScientific Solutions business splits from global medtech company\n\nNews\n\nNew PRECiV software turns any manual microscope into a complete imaging and measurement platform. Learn about the software’s benefits and features in the press release.\n\nNews\n\nThe new 72DL PLUS precision thickness gauge features our lowest ever minimum thickness capability for single and multilayer materials. Get all the details in the press release.\n\nNews\n\nOur new OmniScan X3 64 flaw detector delivers improved power and performance to our field-proven phased array instruments. Read the press release to get all the details.\n\nNews\n\nEarlier this year, Olympus announced its plans to reorganize the Scientific Solutions Division into a self-sustainable company. This reorganization will enable the Scientific Solutions business a greater level of autonomy and agility to respond more quickly and with more flexibility to our industrial and life science customers’ needs.\n\nSee more"
    }
}